Advanced glycation end products and lipopolysaccharides stimulate interleukin‑6 secretion via the RAGE/TLR4‑NF‑κB‑ROS pathways and resveratrol attenuates these inflammatory responses in mouse macrophages

Ohtsu,Ayaka; Shibutani,Yui; Seno,Kotomi; Iwata,Hisataka; Kuwayama,Takehito; Shirasuna,Koumei

doi:10.3892/etm.2017.5045

Advanced glycation end products and lipopolysaccharides stimulate interleukin‑6 secretion via the RAGE/TLR4‑NF‑κB‑ROS pathways and resveratrol attenuates these inflammatory responses in mouse macrophages

Authors:
- Ayaka Ohtsu
- Yui Shibutani
- Kotomi Seno
- Hisataka Iwata
- Takehito Kuwayama
- Koumei Shirasuna
View Affiliations

Affiliations: Laboratory of Animal Reproduction, Department of Animal Science, Tokyo University of Agriculture, Atsugi, Kanagawa 234‑0034, Japan
Published online on: August 28, 2017 https://doi.org/10.3892/etm.2017.5045
Pages: 4363-4370

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Macrophages are essential for regulating the physiology of pregnancy; however, excessive inflammatory responses to macrophages, induced by infection and/or endogenous danger signals, may potentially result in complications during pregnancy. Advanced glycation end‑products (AGE) and lipopolysaccharides (LPS) are known to induce inflammation and are associated with adverse developmental outcomes. The aim of the present study was to examine the effect of AGE and LPS on cytokines in the J774 murine macrophage cell line and the potential effect of resveratrol on AGE‑ and LPS‑induced inflammation in macrophages. AGE and LPS significantly increased IL‑6 mRNA expression and secretion in J774 macrophages (P<0.05). Although AGE and LPS significantly stimulated IL‑1β mRNA expression (P<0.05), they had no significant effect on IL‑1β secretion. To assess the receptors for AGE and LPS, including receptor for AGE (RAGE) and Toll‑like receptor (TLR4), blocking reagents (RAGE antagonist or TLR4 inhibitor) were added to the J774 macrophages. IL‑6 secretion induced by AGE or LPS was significantly inhibited by pretreatment with RAGE antagonist (P<0.05) or TLR4 inhibitor (P<0.05). IL‑6 secretion was dependent on nuclear factor (NF)‑κB activation and the production of reactive oxygen species (ROS; P<0.05). Resveratrol suppressed mRNA expression and intracellular IL‑6 production, resulting in significantly decreased IL‑6 secretion after treatment with LPS or AGE (P<0.01). Furthermore, treatment with Ex527, which is a sirtuin‑1 (SIRT1) inhibitor, significantly attenuated the anti‑inflammatory effect of resveratrol (P<0.05), and treatment with 5‑aminoimidazole‑4‑carboxamide ribonucleotide, which is a 5' adenosine monophosphate‑activated protein kinase (AMPK) activator, resulted in a significant decrease in IL‑6 secretion in J774 macrophages (P<0.05). The results of the present study indicated that AGE and LPS increase IL‑6 secretion depending on NF‑κB activation and ROS production through RAGE and/or TLR4 in the J774 murine macrophage cell line. Based on the present study, resveratrol appears to be an effective regulator of the inflammatory responses associated with SIRT1 and AMPK activation in macrophages. These results suggest that resveratrol may have therapeutic applications for controlling immune responses during pregnancy.

View Figures

View References

1	Laresgoiti-Servitje E: A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 94:247–257. 2013. View Article : Google Scholar : PubMed/NCBI
2	Faas MM, Spaans F and De Vos P: Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol. 5:2982014. View Article : Google Scholar : PubMed/NCBI
3	Care AS, Diener KR, Jasper MJ, Brown HM, Ingman WV and Robertson SA: Macrophages regulate corpus luteum development during embryo implantation in mice. J Clin Invest. 123:3472–3487. 2013. View Article : Google Scholar : PubMed/NCBI
4	Sacks GP, Studena K, Sargent K and Redman CW: Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 179:80–86. 1998. View Article : Google Scholar : PubMed/NCBI
5	Melgert BN, Spaans F, Borghuis T, Klok PA, Groen B, Bolt A, de Vos P, van Pampus MG, Wong TY, van Goor H, et al: Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS One. 7:e452292012. View Article : Google Scholar : PubMed/NCBI
6	Lau SY, Guild SJ, Barrett CJ, Chen Q, McCowan L, Jordan V and Chamley LW: Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: A systematic review and meta-analysis. Am J Reprod Immunol. 70:412–427. 2013.PubMed/NCBI
7	Robertson SA, Skinner RJ and Care AS: Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol. 177:4888–4896. 2006. View Article : Google Scholar : PubMed/NCBI
8	Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP and Hobbins JC: Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol. 161:817–824. 1989. View Article : Google Scholar : PubMed/NCBI
9	Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, Johnson F, Iams JD, Thom E and Andrews WW: The preterm prediction study: Significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 173:1231–1235. 1995. View Article : Google Scholar : PubMed/NCBI
10	Bo QL, Chen YH, Yu Z, Fu L, Zhou Y, Zhang GB, Wang H, Zhang ZH and Xu DX: Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation. Mol Cell Endocrinol. 423:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
11	John WG and Lamb EJ: The Maillard or browning reaction in diabetes. Eye (Lond). 7:230–237. 1993. View Article : Google Scholar : PubMed/NCBI
12	Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol. 5:331–342. 2005. View Article : Google Scholar : PubMed/NCBI
13	Chekir C, Nakatsuka M, Noguchi S, Konishi H, Kamada Y, Sasaki A, Hao L and Hiramatsu Y: Accumulation of advanced glycation end products in women with preeclampsia: Possible involvement of placental oxidative and nitrative stress. Placenta. 27:225–233. 2006. View Article : Google Scholar : PubMed/NCBI
14	Naruse K, Sado T, Noguchi T, Tsunemi T, Yoshida S, Akasaka J, Koike N, Oi H and Kobayashi H: Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: Novel markers of inflammatory response. J Reprod Immunol. 93:69–74. 2012. View Article : Google Scholar : PubMed/NCBI
15	Hao L, Noguchi S, Kamada Y, Sasaki A, Matsuda M, Shimizu K, Hiramatsu Y and Nakatsuka M: Adverse effects of advanced glycation end products on embryonal development. Acta Med Okayama. 62:93–99. 2008.PubMed/NCBI
16	Huang QT, Zhang M, Zhong M, Yu YH, Liang WZ, Hang LL, Gao YF, Huang LP and Wang ZJ: Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: A novel bridge between oxidative stress and preeclampsia. Placenta. 34:1177–1182. 2013. View Article : Google Scholar : PubMed/NCBI
17	Akira S, Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell. 124:783–801. 2006. View Article : Google Scholar : PubMed/NCBI
18	Ibrahim ZA, Armour CL, Phipps S and Sukkar MB: RAGE and TLRs: Relatives, friends or neighbours? Mol Immunol. 56:739–744. 2013. View Article : Google Scholar : PubMed/NCBI
19	Szmitko PE and Verma S: Cardiology patient pages. Red wine and your heart. Circulation. 111:e10–e11. 2005. View Article : Google Scholar : PubMed/NCBI
20	Ponzo V, Soldati L and Bo S: Resveratrol: A supplementation for men or for mice? J Transl Med. 12:1582014. View Article : Google Scholar : PubMed/NCBI
21	Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
22	Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al: Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444:337–342. 2006. View Article : Google Scholar : PubMed/NCBI
23	Wang F, Tian X, Zhang L, He C, Ji P, Li Y, Tan D and Liu G: Beneficial effect of resveratrol on bovine oocyte maturation and subsequent embryonic development after in vitro fertilization. Fertil Steril. 101:577–586. 2014. View Article : Google Scholar : PubMed/NCBI
24	Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L and Cellerino A: Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol. 16:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
25	Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, et al: SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15:675–690. 2012. View Article : Google Scholar : PubMed/NCBI
26	Kawasaki Y, Aoki Y, Magata F, Miyamoto A, Kawashima C, Hojo T, Okuda K, Shirasuna K and Shimizu T: The effect of single nucleotide polymorphisms in the tumor necrosis factor-α gene on reproductive performance and immune function in dairy cattle. J Reprod Dev. 60:173–178. 2014. View Article : Google Scholar : PubMed/NCBI
27	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
28	Brasier AR: The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res. 86:211–218. 2010. View Article : Google Scholar : PubMed/NCBI
29	Yin QQ, Dong CF, Dong SQ, Dong XL, Hong Y, Hou XY, Luo DZ, Pei JJ and Liu XP: AGEs induce cell death via oxidative and endoplasmic reticulum stresses in both human SH-SY5Y neuroblastoma cells and rat cortical neurons. Cell Mol Neurobiol. 32:1299–1309. 2012. View Article : Google Scholar : PubMed/NCBI
30	Lin JK and Tsai SH: Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Repub China B. 23:99–106. 1999.PubMed/NCBI
31	Berbaum K, Shanmugam K, Stuchbury G, Wiede F, Körner H and Munch G: Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine. 41:198–203. 2008. View Article : Google Scholar : PubMed/NCBI
32	Lappas M, Permezel M and Rice GE: Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J Endocrinol. 193:269–277. 2007. View Article : Google Scholar : PubMed/NCBI
33	Liu J, Zhao S, Tang J, Li Z, Zhong T, Liu Y, Chen D, Zhao M, Li Y, Gong X, et al: Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. FEBS J. 276:4598–4606. 2009. View Article : Google Scholar : PubMed/NCBI
34	Chen YJ, Sheu ML, Tsai KS, Yang RS and Liu SH: Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products. PLoS One. 8:e666112013. View Article : Google Scholar : PubMed/NCBI
35	Shim E and Babu JP: Glycated albumin produced in diabetic hyperglycemia promotes monocyte secretion of inflammatory cytokines and bacterial adherence to epithelial cells. J Periodontal Res. 50:197–204. 2015. View Article : Google Scholar : PubMed/NCBI
36	Dragone T, Cianciulli A, Calvello R, Porro C, Trotta T and Panaro MA: Resveratrol counteracts lipopolysaccharide-mediated microglial inflammation by modulating a SOCS-1 dependent signaling pathway. Toxicol In Vitro. 28:1126–1135. 2014. View Article : Google Scholar : PubMed/NCBI
37	Jin X, Yao T, Zhou Z, Zhu J, Zhang S, Hu W and Shen C: Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway. Biomed Res Int. 2015:7324502015. View Article : Google Scholar : PubMed/NCBI
38	Schroder K, Zhou R and Tschopp J: The NLRP3 inflammasome: A sensor for metabolic danger? Science. 327:296–300. 2010. View Article : Google Scholar : PubMed/NCBI
39	Takahashi M: Role of the inflammasome in myocardial infarction. Trends Cardiovasc Med. 21:37–41. 2011. View Article : Google Scholar : PubMed/NCBI
40	Ott C, Jacobs K, Haucke E, Santos Navarrete A, Grune T and Simm A: Role of advanced glycation end products in cellular signaling. Redox Biol. 2:411–429. 2014. View Article : Google Scholar : PubMed/NCBI
41	Vénéreau E, Ceriotti C and Bianchi ME: DAMPs from cell death to new life. Front Immunol. 6:4222015. View Article : Google Scholar : PubMed/NCBI
42	Cheng A, Dong Y, Zhu F, Liu Y, Hou FF and Nie J: AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells. Int J Biol Sci. 9:94–107e. 2013. View Article : Google Scholar : PubMed/NCBI
43	Shirasuna K, Seno K, Ohtsu A, Shiratsuki S, Ohkuchi A, Suzuki H, Matsubara S, Nagayama S, Iwata H and Kuwayama T: AGEs and HMGB1 increase inflammatory cytokine production from human placental cells, resulting in an enhancement of monocyte migration. Am J Reprod Immunol. 75:557–568. 2016. View Article : Google Scholar : PubMed/NCBI
44	Shirasuna K, Takano H, Seno K, Ohtsu A, Karasawa T, Takahashi M, Ohkuchi A, Suzuki H, Matsubara S, Iwata H and Kuwayama T: Palmitic acid induces interleukin-1β secretion via NLRP3 inflammasomes and inflammatory responses through ROS production in human placental cells. J Reprod Immunol. 116:104–112. 2016. View Article : Google Scholar : PubMed/NCBI
45	Ishibashi Y, Matsui T, Takeuchi M and Yamagishi S: Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1. Horm Metab Res. 43:619–624. 2011. View Article : Google Scholar : PubMed/NCBI
46	Feng L, Zhu MM, Zhang MH, Wang RS, Tan XB, Song J, Ding SM, Jia XB and Hu SY: Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells. J Ethnopharmacol. 148:27–36. 2013. View Article : Google Scholar : PubMed/NCBI
47	Lorne E, Dupont H and Abraham E: Toll-like receptors 2 and 4: Initiators of non-septic inflammation in critical care medicine? Intensive Care Med. 36:1826–1835. 2010. View Article : Google Scholar : PubMed/NCBI
48	Yi CO, Jeon BT, Shin HJ, Jeong EA, Chang KC, Lee JE, Lee DH, Kim HJ, Kang SS, Cho GJ, et al: Resveratrol activates AMPK and suppresses LPS-induced NF-κB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anat Cell Biol. 44:194–203. 2011. View Article : Google Scholar : PubMed/NCBI
49	Lappas M, Mitton A, Lim R, Barker G, Riley C and Permezel M: SIRT1 is a novel regulator of key pathways of human labor. Biol Reprod. 84:167–178. 2011. View Article : Google Scholar : PubMed/NCBI
50	Nakamaru Y, Vuppusetty C, Wada H, Milne JC, Ito M, Rossios C, Elliot M, Hogg J, Kharitonov S, Goto H, et al: A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J. 23:2810–2819. 2009. View Article : Google Scholar : PubMed/NCBI
51	Labuzek K, Liber S, Gabryel B, Bułdak L and Okopień B: Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures. Naunyn Schmiedebergs Arch Pharmacol. 381:41–57. 2010. View Article : Google Scholar : PubMed/NCBI
52	Furuya H, Taguchi A, Kawana K, Yamashita A, Inoue E, Yoshida M, Nakamura H, Fujimoto A, Inoue T, Sato M, et al: Resveratrol protects against pathological preterm birth by suppression of macrophage-mediated inflammation. Reprod Sci. 22:1561–1568. 2015. View Article : Google Scholar : PubMed/NCBI
53	Chen L, Yang S, Zumbrun EE, Guan H, Nagarkatti PS and Nagarkatti M: Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages. Mol Nutr Food Res. 59:853–864. 2015. View Article : Google Scholar : PubMed/NCBI